Literature DB >> 24034312

The faces of personalized medicine: a framework for understanding its meaning and scope.

W Ken Redekop1, Deirdre Mladsi.   

Abstract

The objective of this article was to provide a framework for understanding the different definitions of the term "personalized medicine." The term personalized medicine is used regularly but interpreted in different ways. This article approaches the term by starting with a broad view of clinical medicine, where three components can be distinguished: the questions (e.g., what is the diagnosis?), the methods used to answer them (e.g., a test), and the available actions (e.g., to give or not give a particular drug). Existing definitions of personalized medicine disagree about which questions, methods, and actions fall within its domain. Some define the term narrowly, referring to the use of a diagnostic test to predict drug response, thereby clarifying whether or not a patient will benefit from that drug. An example of this combination is the HER2/neu test to predict the effectiveness of trastuzumab in breast cancer. Many who adopt this definition associate the concept of personalized medicine with fields such as genetics, genomics, and other types of "-omics." In contrast, others view personalized medicine as a concept that has always existed, because medicine has always considered the needs of the individual. One definition of personalized medicine that accommodates both interpretations is "the use of combined knowledge (genetic or otherwise) about a person to predict disease susceptibility, disease prognosis, or treatment response and thereby improve that person's health." This predictive ability can increase over time through innovations in various technologies, resulting in further improvements in health outcomes. Moreover, these developments can lead to a better understanding of the underlying causes of disease, which can eventually lead to breakthroughs in the treatment of individual patients. In that sense, a truly personalized form of medicine can also be seen as an ideal, a goal that will be achieved only after multiple advances in science. Although the term personalized medicine was rechristened somewhat recently, our ability to personalize medicine will continue to advance in unimaginable ways as we come to learn more about the heterogeneity that exists among individuals and diseases.
Copyright © 2013, International Society for Pharmacoeconomics and Outcomes Research (ISPOR). Published by Elsevier Inc.

Entities:  

Keywords:  companion diagnostic; diagnostic test; individualized medicine; personalized medicine; pharmacogenetics; stratified medicine

Mesh:

Year:  2013        PMID: 24034312     DOI: 10.1016/j.jval.2013.06.005

Source DB:  PubMed          Journal:  Value Health        ISSN: 1098-3015            Impact factor:   5.725


  37 in total

1.  Understanding patient outcomes after acute respiratory distress syndrome: identifying subtypes of physical, cognitive and mental health outcomes.

Authors:  Samuel M Brown; Emily L Wilson; Angela P Presson; Victor D Dinglas; Tom Greene; Ramona O Hopkins; Dale M Needham
Journal:  Thorax       Date:  2017-08-04       Impact factor: 9.139

2.  Association Between 6-Week Postdischarge Risk Classification and 12-Month Outcomes After Orthopedic Trauma.

Authors:  Renan C Castillo; Yanjie Huang; Daniel Scharfstein; Katherine Frey; Michael J Bosse; Andrew N Pollak; Heather A Vallier; Kristin R Archer; Robert A Hymes; Anna B Newcomb; Ellen J MacKenzie; Stephen Wegener; Joseph R Hsu; Madhav A Karunakar; Rachel B Seymour; Stephen H Sims; Eileen Flores; Christine Churchill; David J Hak; Corey E Henderson; Hassan R Mir; Daniel S Chan; Anjan R Shah; Barbara Steverson; Jerald Westberg; Joshua L Gary; Timothy S Achor; Andrew Choo; John W Munz; Melissa Porrey; Sarah Hendrickson; Mary A Breslin; Todd O McKinley; Greg E Gaski; Laurence B Kempton; Anthony T Sorkin; Walter W Virkus; Lauren C Hill; Clifford B Jones; Debra L Sietsema; Robert V O'Toole; Katherine Ordonio; Andrea L Howe; Timothy J Zerhusen; William Obremskey; Robert H Boyce; A Alex Jahangir; Cesar S Molina; Manish K Sethi; Susan W Vanston; Eben A Carroll; Danielle Yemiola Drye; Martha B Holden; Susan C Collins; Elizabeth Wysocki
Journal:  JAMA Surg       Date:  2019-02-20       Impact factor: 14.766

3.  Are the Origins of Precision Medicine Found in the Corpus Hippocraticum?

Authors:  Meropi K Konstantinidou; Makrina Karaglani; Maria Panagopoulou; Aliki Fiska; Ekaterini Chatzaki
Journal:  Mol Diagn Ther       Date:  2017-12       Impact factor: 4.074

4.  Some economics on personalized and predictive medicine.

Authors:  F Antoñanzas; C A Juárez-Castelló; R Rodríguez-Ibeas
Journal:  Eur J Health Econ       Date:  2014-11-08

Review 5.  Toward precision medicine of breast cancer.

Authors:  Nicolas Carels; Lizânia Borges Spinassé; Tatiana Martins Tilli; Jack Adam Tuszynski
Journal:  Theor Biol Med Model       Date:  2016-02-29       Impact factor: 2.432

Review 6.  Physiologically-based pharmacokinetic models: approaches for enabling personalized medicine.

Authors:  Clara Hartmanshenn; Megerle Scherholz; Ioannis P Androulakis
Journal:  J Pharmacokinet Pharmacodyn       Date:  2016-09-19       Impact factor: 2.745

7.  Gender-associated differences in oral microbiota and salivary biochemical parameters in response to feeding.

Authors:  M Minty; P Loubières; T Canceill; V Azalbert; R Burcelin; F Tercé; V Blasco-Baque
Journal:  J Physiol Biochem       Date:  2020-07-09       Impact factor: 4.158

Review 8.  Artificial Intelligence in Obstetrics and Gynaecology: Is This the Way Forward?

Authors:  Sonji Clarke; Michail Sideris; Elif Iliria Emin; Ece Emin; Apostolos Papalois; Fredric Willmott
Journal:  In Vivo       Date:  2019 Sep-Oct       Impact factor: 2.155

9.  Personalized Medicine and Pay for Performance: Should Pharmaceutical Firms be Fully Penalized when Treatment Fails?

Authors:  Fernando Antoñanzas; Roberto Rodríguez-Ibeas; Carmelo A Juárez-Castelló
Journal:  Pharmacoeconomics       Date:  2018-07       Impact factor: 4.981

10.  Latent Profiles of Health and Reproductive Risk and Protective Factors among Women in Appalachia.

Authors:  Braden K Linn; Gretchen E Ely; Michele Staton
Journal:  J Soc Work Pract Addict       Date:  2020-04-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.